Cannabis Bioscience International Holdings, Inc. cash flow statement CBIH

In fiscal 2025, which ended May 31, 2025, Cannabis Bioscience International Holdings, Inc. used $329,627 of cash from operations, up 31.2% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Feb 28, 2026
FY 2025
May 31, 2025
FY 2024
May 31, 2024
Operating
Stock-based compensation
—
—
0
Operating cash flow
-0
+25.5%
-0
+31.2%
-0
Financing
Short-term debt issued
—
—
0
Financing cash flow
0
-25.5%
0
-27.5%
0
Ratios
Stock-based compensation to revenue
—
—
0.00%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
CBIH (OTC)
Fiscal year ends
May 31
Incorporated in
CO
Headquarters
Yantis, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1411057
Former names
CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.